Skip to content
AwardedFranceServices

Sous-Traitance RHU Systinn: Etudes de toxicologie règlementaire

Published
Published 18 September 2025

Overview

Le Réseau Hospitalo-Universitaire (RHU) SyStInn porté par le Pr Dumontet et soutenu par l'Agence Nationale de la Recherche (ANR) a pour objectif d'évaluer le potentiel anticancéreux d'un stimulant du système immunitaire inné en clinique, HEPHA-440. En vue d'obtenir une approbation d'utilisation chez l'humain par les agences réglementaires de santé, il est nécessaire au préalable de tester la toxicité d'HEPHA-440 chez l'animal sur l'ensemble de l'organisme selon les normes en vigueur appelées « Bonnes Pratiques de Laboratoire » (BPL).

Key details

Country
France
Status
Awarded
Category
Services
Procedure
Open
Published
18 September 2025
Classification (CPV)
Research laboratory servicesServices provided by medical laboratoriesDomestic animal nurseries

Award outcome

Awarded value
€553,788
Award date
26 August 2025
Winner
  • C.RIS Pharma

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    18 September 2025

Contracting authority

  • Université Cluade BERNARD Lyon 1

    Procuring entity

    Villeurbanne CEDEX, France

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Sous-Traitance RHU Systinn: Etudes de toxicologie règlementaire — won by C.RIS Pharma — Skim